| 摘要 |
This application relates to novel compounds of formula (I), and their pharmaceutically acceptable salts, as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of the compounds of formula (I) as thrombin inhibitors.
|
| 申请人 |
ELI LILLY AND COMPANY |
发明人 |
BASTIAN, JOLIE ANNE;ZHANG, MINSHENG;JOHNSON, MARY GEORGE;HARPER, RICHARD WALTZ;RICHETT, MICHAEL ENRICO;WILEY, MICHAEL ROBERT;CHIRGADZE, NICKOLAY YURI;DENNEY, MICHAEL LYLE;SMITH, GERALD FLOYD;LYNCH, MICHAEL PATRICK;MILLER, SHAWN CHRISTOPHER;SALL, DANIEL JON;MCCOWAN, JEFFERSON RAY;LIN, HO-SHEN;TAKEUCHI, KUMIKO;MULLANEY, JEFFREY THOMAS;TINSLEY, JENNIFER MARIE;FISHER, MATTHEW JOSEPH;KLIMKOWSKI, VALENTINE JOSEPH;FOGLESONG, ROBERT JAMES |
